OVID Stock Latest News

Ovid Therapeutics reports Q3 EPS (20c), consensus (20c)

PremiumThe Fly

1M ago

Ovid Therapeutics presents study results on OV329

PremiumThe Fly

3M ago

Ovid Therapeutics Elevates Meg Alexander to President and COO

PremiumCompany Announcements

3M ago

Ovid Therapeutics appoints Alexander as President, COO

PremiumThe Fly

3M ago

PremiumThe FlyOvid Therapeutics actively evaluating pipeline

4M ago

The Fly

Ovid Therapeutics reduces headcount by 43%

4M ago

The Fly

Ovid Therapeutics reports cash position of $77M as of June 30

4M ago

Ovid Therapeutics reports Q2 EPS 12c, consensus (22c)

PremiumThe Fly

4M ago

Ovid Therapeutics appoints Banks as Chief Development Officer

PremiumThe Fly

5M ago

OVID Earnings this Week: How Will it Perform?

PremiumPre-Earnings

5M ago

Ovid Therapeutics Announces Leadership Transition and Consulting Deal

PremiumCompany Announcements

5M ago

PremiumThe FlyOvid Therapeutics expands scientific advisory board

5M ago

The Fly

Ovid Therapeutics announces eNeuro published studies on OV329 mechanism

6M ago

The Fly

Ovid Therapeutics, Graviton announce data from trial of OV888/GV101 capsule

6M ago

Ovid Therapeutics Announces Workforce Reduction to Extend Runway

PremiumCompany Announcements

6M ago

Biotech Alert: Searches spiking for these stocks today

PremiumThe Fly

6M ago

Biotech Alert: Searches spiking for these stocks today

ARDX

PremiumThe Fly

6M ago

Apple downgraded, Kroger upgraded: Wall Street’s top analyst calls

AVTE

PremiumThe Fly

6M ago

GSK

PremiumThe FlyOvid Therapeutics price target lowered to $3 from $9 at B. Riley

6M ago

The Fly

Oppenheimer downgrades Ovid Therapeutics to Perform following Soticlestat misses

6M ago

The Fly

Ovid Therapeutics price target lowered to $2 from $7 at Ladenburg

6M ago